Use of the da Vinci® Surgical System for robotic-assisted prostate cancer surgery is quickly becoming the gold standard for treatment. In addition to smaller incisions and a faster recovery, recent studies suggest that robotic prostate surgery may offer improved cancer control and a lower incidence of impotence and urinary incontinence due to the precise, nerve-sparing nature of the procedure.
The most recommended treatment option for men under 70 with early-stage, organ-confined cancer is surgical removal of the prostate (prostatectomy). The primary goal of prostatectomy is removal of the cancer. A secondary, but very important goal is to preserve urinary function and erectile function by preserving the necessary nerves that run alongside the prostate. These nerves are often damaged when removing the prostate. A nerve-sparing prostatectomy attempts to preserve these nerves so that the patient will regain normal control after surgery.
Though any diagnosis of cancer can be traumatic, the good news is that if your doctor recommends prostate surgery, the cancer was probably caught early. And, with robotic prostatectomy, the likelihood of a complete recovery from prostate cancer without long-term side effects is, for most patients, better than it has ever been.
The da Vinci robotic surgical system enables surgeons to operate with unmatched precision and control using only a few small incisions.
Recent studies suggest that this method of prostate surgery may offer improved cancer control and a faster return to potency and continence. It also offers these potential benefits when compared with traditional open surgery:
- Significantly less pain
- Less blood loss
- Fewer complications
- Less scarring
- A shorter hospital stay
- And a faster return to normal daily activities
To learn if you are a candidate for robotic prostate surgery, talk to a surgeon who performs the procedure.
See animation of robotic prostate surgery